Ambu A/SAMBU-B.CO

Nasdaq CopenhagenHealthcareMedical Devices
Price (close)
DKK 68.20
Market cap
DKK 17.8B
P/E
29.2x
Revenue (FY)
DKK 6.0B
Net income
DKK 609.0M
Dividend yield
0.60%
1-year total return
-30.4%
Net margin
10.1%
Revenue growth
12.0%
Debt / equity
0.00x

What Ambu A/S does.

Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes. It also provides airway management and anaesthesia products, which include double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers emergency care and training products, such as extrication collars and ALS and BLS training manikins, as well as mobile workstations, IOMs, and patient monitoring and diagnostics devices. Further, the company manufactures video capture solutions for OEMs in medical and defense imaging applications. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.

Revenue and profit, by fiscal year.

Fiscal year20212022202320242025
RevenueDKK 4.0BDKK 4.4BDKK 4.8BDKK 5.4BDKK 6.0B
Net incomeDKK 247.0MDKK 93.0MDKK 168.0MDKK 235.0MDKK 609.0M
Free cash flowDKK 152.0M-DKK 43.0MDKK 447.0MDKK 725.0MDKK 674.0M

More on AMBU-B.CO.

Figures from Ambu A/S's annual reports (ESEF, via filings.xbrl.org) and Yahoo Finance, standardised automatically; prices are end-of-day closes. Not financial advice.